Stock ARVN ARVINAS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Arvinas, Inc.

Equities

ARVN

US04335A1051

Real-time Estimate Cboe BZX
Other stock markets
 01:54:07 2024-05-13 pm EDT 		5-day change 1st Jan Change
31.78 USD +1.07% Intraday chart for Arvinas, Inc. -1.52% -22.81%
May. 08 Oppenheimer Adjusts Arvinas Price Target to $70 From $80, Maintains Outperform Rating MT
May. 07 Arvinas Shares Up After Q1 Net Loss Narrows MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
ARVINAS, INC. Stock Arvinas, Inc.
 2.15B -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 109B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 105B
ARGENX SE Stock argenx SE
 22.25B -
BIONTECH SE Stock BioNTech SE
 22.09B -
GENMAB A/S Stock Genmab A/S
 18.68B
  1. Stock Market
  2. Equities
  3. ARVN Stock
  4. Charts Arvinas, Inc.
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW